Are you Dr. Rosebraugh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
17316 Avenleigh Dr
Ashton, MD 20861Phone+1 301-570-0843
Summary
- Dr. Curtis Rosebraugh, MD is a board certified internist in Ashton, Maryland. He is currently licensed to practice medicine in Maryland, District of Columbia, and Texas.
Education & Training
University of Kansas School of MedicineResidency, Internal Medicine, 1986 - 1989- University of Kansas School of MedicineClass of 1986
Certifications & Licensure
KS State Medical License 1989 - 2025
MD State Medical License 1998 - 2025
DC State Medical License 1998 - 2020
TX State Medical License 1994 - 2000- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 89 citationsThe U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial.Anthony G. Durmowicz, Robert Lim, Hobart Rogers, Curtis J. Rosebraugh, Badrul A. Chowdhury
Annals of the American Thoracic Society. 2018-01-01 - 2 citationsDosing of Etelcalcetide and Cinacalcet for Secondary Hyperparathyroidism.Mary T. Thanh Hai, Jean-Marc Guettier, Curtis J. Rosebraugh
JAMA. 2017-05-23 - 348 citationsPancreatic safety of incretin-based drugs--FDA and EMA assessment.Amy Egan, Eberhard Blind, Kristina Dunder, Pieter A. de Graeff, B. Timothy Hummer
The New England Journal of Medicine. 2014-02-26
Press Mentions
FDA Approves New Treatment for People with COPDAugust 1st, 2014- FDA Approves New Type 2 Diabetes DrugAugust 1st, 2014
FDA Approves Otezla to Treat Psoriatic ArthritisFebruary 10th, 2016
